MRK Price / Book | Merck & Co., Inc.

Merck & Co., Inc. (MRK) Price / Book

2026-09-03: Price/Book Ratio 8.96.
2026-06-30: Price/Book Ratio 7.57.
2026-03-31: Price/Book Ratio 6.48.
2025-12-31: Price/Book Ratio 4.97.

Historical market capitalization divided by filed shareholder equity.

Available history: 2009-09-30 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	8.96
2026-06-30	7.57
2026-03-31	6.48
2025-12-31	4.97
2025-09-30	4.04
2025-06-30	4.06
2025-03-31	4.69
2024-12-31	5.43
2024-09-30	6.47
2024-06-30	7.19
2024-03-31	8.28
2023-12-31	7.35
2023-09-30	6.33
2023-06-30	7.57
2023-03-31	5.77
2022-12-31	6.12
2022-09-30	4.91
2022-06-30	5.33
2022-03-31	5.07
2021-12-31	5.07
2021-09-30	5.31
2021-06-30	5.91
2021-03-31	6.91
2020-12-31	7.8
2020-09-30	6.86
2020-06-30	6.74
2020-03-31	7.11
2019-12-31	8.53
2019-09-30	7.66
2019-06-30	7.45
2019-03-31	7.44
2018-12-31	7.1
2018-09-30	5.55
2018-06-30	4.79
2018-03-31	4.16
2017-12-31	4.26
2017-09-30	4.36
2017-06-30	4.24
2017-03-31	4.18
2016-12-31	3.86
2016-09-30	3.76
2016-06-30	3.51
2016-03-31	3.2
2015-12-31	3.15
2015-09-30	2.91
2015-06-30	3.3
2015-03-31	3.26
2014-12-31	3.18
2014-09-30	3.61
2014-06-30	3.34
2014-03-31	3.19
2013-12-31	2.8
2013-09-30	2.8
2013-06-30	2.82
2013-03-31	2.4
2012-12-31	2.24
2012-09-30	2.35
2012-06-30	2.2
2012-03-31	2.03
2011-12-31	2.01
2011-09-30	1.74
2011-06-30	1.87
2011-03-31	1.79
2010-12-31	1.95
2010-09-30	1.94
2010-06-30	1.88
2010-03-31	1.92
2009-12-31	0.97
2009-09-30	3.84

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
AbbVie Inc. (ABBV)	United States	$468.180B	70.37
ABBOTT LABORATORIES (ABT)	United States	$176.045B	28.47
PFIZER INC (PFE)	United States	$162.042B	31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)	United States	$132.481B	28.56
BRISTOL MYERS SQUIBB CO (BMY)	United States	$125.637B	12.67
JOHNSON & JOHNSON (JNJ)	United States	$652.528B	29.10
REGENERON PHARMACEUTICALS, INC. (REGN)	United States	$74.751B	21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)	United States	$33.420B	54.94
Zoetis Inc. (ZTS)	United States	$29.045B	11.38
INSMED Inc (INSM)	United States	$26.566B	-26.60